Avalo Therapeutics, Inc.
USD19.37
+1.49 (+8.33%)
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.93
Prev. Close
$17.88
Day Low
$17.54
Day High
$19.48
52W Low
$6.21
52W High
$24.27
Market Cap
$0.22B
Volume
1.24M
| 1,779 |
| $8.04 |
| 2 Jul 2026 | Doyle Mittie | Chief Medical Officer | S-Sale | Disposed | 4,654 | $20.00 |
| 2 Jul 2026 | Doyle Mittie | Chief Medical Officer | M-Exempt | Disposed | 2,875 | $12.65 |
| 2 Jul 2026 | Doyle Mittie | Chief Medical Officer | M-Exempt | Disposed | 1,779 | $8.04 |
| 2 Jul 2026 | Philip Ron M | director | A-Award | Acquired | 69 | $18.48 |
| 2 Jul 2026 | Lind Kevin Robert | director | A-Award | Acquired | 1,105 | $18.48 |
| 2 Jul 2026 | Jain Rita | director | A-Award | Acquired | 1,080 | $18.48 |
| 25 Jun 2026 | Doyle Mittie | Chief Medical Officer | M-Exempt | Acquired | 1,450 | $8.04 |
| 25 Jun 2026 | Doyle Mittie | Chief Medical Officer | S-Sale | Disposed | 1,450 | $18.00 |